Guizhou Sanli PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Guizhou Sanli PharmaceuticalLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥577.7M, which brings its debt-to-equity ratio to 31.1%. Its total assets and total liabilities are CN¥3.1B and CN¥1.2B respectively. Guizhou Sanli PharmaceuticalLtd's EBIT is CN¥342.9M making its interest coverage ratio -6.8. It has cash and short-term investments of CN¥593.1M.
Key information
31.1%
Debt to equity ratio
CN¥577.72m
Debt
| Interest coverage ratio | -6.8x |
| Cash | CN¥593.10m |
| Equity | CN¥1.86b |
| Total liabilities | CN¥1.20b |
| Total assets | CN¥3.06b |
Recent financial health updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Passed With Ease
Oct 16
Little Excitement Around Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Earnings
Aug 25Is Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Trading At A 20% Discount?
Aug 03Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 23Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly
Mar 25Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 06Financial Position Analysis
Short Term Liabilities: 603439's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥845.7M).
Long Term Liabilities: 603439's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥355.2M).
Debt to Equity History and Analysis
Debt Level: 603439 has more cash than its total debt.
Reducing Debt: 603439's debt to equity ratio has increased from 0% to 31.1% over the past 5 years.
Debt Coverage: 603439's debt is well covered by operating cash flow (31.8%).
Interest Coverage: 603439 earns more interest than it pays, so coverage of interest payments is not a concern.